Skip to main content
Clinical Trials/NL-OMON48569
NL-OMON48569
Recruiting
Not Applicable

Validation of ultrahigh field (7 Tesla) MRI with whole mount pathology in rectal cancer - 7MaRC

niversitair Medisch Centrum Utrecht0 sites10 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
rectal cancer
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
10
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • \* Informed consent for PLCRC;
  • \* Informed consent for the use of clinical data
  • \* Informed consent for future studies within PLCRC;
  • \* Eligible for neoadjuvant radiotherapy;
  • \* Eligible for rectal surgery by Total Mesorectal Excision (either Low Anterior Resection, Abdominoperineal Resection or Hartmann resection).

Exclusion Criteria

  • \* Patients with distant metastasis requiring surgery between chemoradiation and rectal surgery;
  • \* MRI contraindications according to the MR safety protocol of the imaging division of the UMC Utrecht.

Outcomes

Primary Outcomes

Not specified

Similar Trials